Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Oatly Publishes Swedish Annual Report for 2025 (GlobeNewswire EN) +++ OATLY Aktie -4,21%

ELANCO Aktie

 >ELANCO Aktienkurs 
19.3 EUR    -0.6%    (TradegateBSX)
Ask: 18.89 EUR / 1060 Stück
Bid: 18.795 EUR / 1070 Stück
Tagesumsatz: 150 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELANCO Aktie über LYNX handeln
>ELANCO Performance
1 Woche: -3,8%
1 Monat: -3,8%
3 Monate: -7,9%
6 Monate: +2,1%
1 Jahr: +134,9%
laufendes Jahr: -0,1%
>ELANCO Aktie
Name:  ELANCO ANIMAL HEALTH.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US28414H1032 / A2N6BH
Symbol/ Ticker:  5EA (Frankfurt) / ELAN (NYSE)
Kürzel:  FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN
Index:  -
Webseite:  https://www.elanco.com/
Profil:  Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion anim..
>Volltext..
Marktkapitalisierung:  9539.01 Mio. EUR
Unternehmenswert:  12590.85 Mio. EUR
Umsatz:  4022.54 Mio. EUR
EBITDA:  795.12 Mio. EUR
Nettogewinn:  -197.93 Mio. EUR
Gewinn je Aktie:  -0.4 EUR
Schulden:  3532.84 Mio. EUR
Liquide Mittel:  464.96 Mio. EUR
Operativer Cashflow:  477.76 Mio. EUR
Bargeldquote:  0.34
Umsatzwachstum:  -6.38%
Gewinnwachstum:  -160.5%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ELANCO
Letzte Datenerhebung:  28.04.26
>ELANCO Kennzahlen
Aktien/ Unternehmen:
Aktien: 499.38 Mio. St.
Frei handelbar: 99.09%
Rückkaufquote: -
Mitarbeiter: 9900
Umsatz/Mitarb.: 0.41 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 29.95%
Bewertung:
KGV: -
KGV lG: 21.75
KUV: 2.35
KBV: 1.71
PEG-Ratio: -
EV/EBITDA: 15.84
Rentabilität:
Bruttomarge: 43.48%
Gewinnmarge: -4.92%
Operative Marge: 5.34%
Managementeffizenz:
Gesamtkaprendite: -1.79%
Eigenkaprendite: -3.67%
>ELANCO Peer Group
Gesundheit, Tiermedizin/ Tierbehandlung
 
28.04.26 - 00:27
Elanco′s Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock (PR Newswire)
 
Action Prepares Veterinarians and Livestock Producers with Prevention and Treatment Options Prior to Fly Being Detected in the U.S. Federal agencies grant emergency authorizations for New World screwworm in livestock, reinforcing Elanco's leadership in livestock health innovations Actions......
24.04.26 - 15:03
National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer (Business Wire)
 
AUSTIN, Texas--(BUSINESS WIRE)--National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. “I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ: ACHC), a leader in the behavioral healthcare industry, where he drove financial discipline and operational performance across its network. Before Acadia, Young served as EVP and CFO at Elanco (NYSE: ELAN), one of the world's largest independent animal health companies, where...
16.04.26 - 14:06
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement (PR Newswire)
 
INDIANAPOLIS, April 16, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2026 financial results on Wednesday, May 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail......
09.04.26 - 14:30
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* (PR Newswire)
 
Breaks the flea lifecycle* with Pyriproxyfen, an insect growth regulator, preventing fleas from reinfesting the dog Adjustable collar fits comfortably and securely on a dog of any size Strengthens Elanco's 25-year Advantage brand family Available at pet specialty, dollar, grocery and mass......
24.03.26 - 00:12
Stocks Rise, Oil Falls as Trump Eases Iran Threats | The Close 3/23/2026 (Bloomberg)
 
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Kestra Investment Management CIO Kara Murphy, Sidley Austin's Kai Liekefett, Cain CEO Jonathan Goldstein, Veriten's Arjun Murti, Schwab Center for Financial Research's Kevin Gordon, Bank of America's Carlos Fernandez-Aller, Evercore ISI's Julian Emanuel, Elanco Animal Health CEO Jeff Simmons, Macerich President & CEO Jack Hsieh, & Ellington CEO Michael Vranos. (Source: Bloomberg)...
23.03.26 - 22:42
Elanco CEO on Robust Outlook for Farmers, Protein Demand (Bloomberg)
 
Elanco Animal Health CEO Jeff Simmons discusses global supply chains, the current protein 'craze,' and the robust outlook for US farmers. He talks with Katie Greifeld and Romaine Bostick on "The Close." (Source: Bloomberg)...
18.03.26 - 21:06
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board (GlobeNewswire EN)
 
PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced that Kathy Turner has been appointed to its Board of Directors, effective April 1, 2026. Ms. Turner replaces Steven Rosgen, who is retiring from the Board after serving since January 2018. Upon joining the Board, Ms. Turner will serve as Chair of the Compensation and Stock Option Committee and as a member of the Audit Committee....
18.03.26 - 13:30
Elanco Animal Health (ELAN) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
 
Elanco Animal Health (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....
17.03.26 - 16:54
XETR: Deletion of Instruments from XETRA - 17.03.2026 (XETRA)
 
The following instruments on XETRA do have their last trading day on 17.03.2026. Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 17.03.2026. ISIN Name IE00BF0L3536 AIB Group PLC US03076C1062 Ameriprise Financial Inc. US0708301041 Bath & Body Works Inc. US12541W2098 C.H. Robinson Worldwide Inc. US03073E1055 Cencora Inc. US1258961002 CMS Energy Corp. US2371941053 Darden Restaurants Inc. US28414H1032 Elanco Animal Health Inc. US29364G1031 Entergy Corp. US2944291051 Equifax Inc. US29452E1010 Equitable Holdings Inc. US31620M1062 Fidelity National Information Services Inc. US34959J1088 Fortive Corp. US35137L1052 Fox Corp. US3647601083 Gap Inc. US4165151048 Hartford Insurance Group Inc. US8326964058 J.M. Smucker Co. IE0004927939 Kingspan Group PLC US5178341070 Las Vegas Sands Corp. US5261071071 Lennox International Inc. US5717481023 Marsh & McLennan Cos. Inc. US6558441084 Norfolk Southern Corp. US7445731067 Public Service Enterprise Group Inc. US7591EP1005 Regio...
17.03.26 - 16:18
Elanco auf dem KeyBanc Forum: Starke Performance und strategische Wachstumspläne (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.03.26 - 22:24
Elanco auf der Leerink Global Healthcare Konferenz: Innovation und Wachstum als treibende Kräfte (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.03.26 - 03:06
Elanco: Starkes Wachstum und optimistische Prognose für 2026 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.03.26 - 16:42
Elanco: Customer-Obsession, Curiosity, Moonshots: Sumit Singh (Accesswire)
 
By Jeff Simmons, President & CEO at Elanco NORTHAMPTON, MA / ACCESS Newswire / March 5, 2026 / From the McDonald's Golden Arches to the Nike Swoosh, these brands have loyal customer bases that ofte......
03.03.26 - 01:24
Elanco auf TD Cowen Konferenz: Strategisches Wachstum und Branchenausblick (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.26 - 19:24
Elanco auf dem BofA Securities Summit: Strategisches Wachstum im Fokus/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.26 - 18:42
Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.26 - 16:48
Elanco hits 52-week high after Q4 results as 2026 outlook beats consensus (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.26 - 16:45
Elanco Animal Health (ELAN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
24.02.26 - 16:24
Elanco (ELAN) Q4 2025 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.26 - 16:00
Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Surpass Estimates (Zacks)
 
Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +16.07% and +4.72%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Am meisten Platz ist zu Hause. - Sprichwort Serbien
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!